Cargando…
Breast Cancer Brain Metastasis: The Potential Role of MRI Beyond Current Clinical Applications
PURPOSE: Breast cancer brain metastasis (BCBM) represents a major clinical challenge. Can MRI help in advancements in the management of BCBM? This review discusses MRI developments and the corresponding potential advancements in BCBM management. METHODS: An exhaustive literature search was undertake...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567538/ https://www.ncbi.nlm.nih.gov/pubmed/33116852 http://dx.doi.org/10.2147/CMAR.S252801 |
_version_ | 1783596344740413440 |
---|---|
author | Hadjipanteli, Andria Doolan, Paul Kyriacou, Efthyvoulos Constantinidou, Anastasia |
author_facet | Hadjipanteli, Andria Doolan, Paul Kyriacou, Efthyvoulos Constantinidou, Anastasia |
author_sort | Hadjipanteli, Andria |
collection | PubMed |
description | PURPOSE: Breast cancer brain metastasis (BCBM) represents a major clinical challenge. Can MRI help in advancements in the management of BCBM? This review discusses MRI developments and the corresponding potential advancements in BCBM management. METHODS: An exhaustive literature search was undertaken to identify studies which look into the potential of MRI in BCBM management. Seven hundred and eighty-four studies published from September 1984 to May 2020 were identified. Three topics are covered where MRI is not clinically established yet: 1) the prognosis of BCBM; 2) the screening of BC patients for BCBM development, and 3) the assessment of imaging features correlated to BC subtype. RESULTS: Thirty-six studies were considered eligible for the purposes of this review. On-going progress is made with the identification of different BCBM characteristics and MRI metrics that might be related to prognosis. Progress has been made with the identification of different BCBM characteristics, including BCBM location, degree of edema, white matter disruption, tumor edge sharpness, and temporal muscle thickness. A more accurate prediction of prognosis could lead to more suitable patient management and treatment. The use of MRI in BCBM screening of the high-risk breast cancer population remains a controversial subject. To date, there are no results from clinical trials; however, there is a rising number of relatively small studies that show concern on this subject and support BCBM screening. It is important to oncologists to be able to assess the tumor subtype non-invasively. MRI features, which have shown some correlation with subtype, include the number of tumors, location, and their distribution in the brain. Advanced tools and metrics have been produced to carry out radiological characteristics analysis on MRI images. Assessing MRI features in more detail could provide a more personalized management of patients. CONCLUSION: Developments in the use of MRI have the potential to improve BCBM management. |
format | Online Article Text |
id | pubmed-7567538 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-75675382020-10-27 Breast Cancer Brain Metastasis: The Potential Role of MRI Beyond Current Clinical Applications Hadjipanteli, Andria Doolan, Paul Kyriacou, Efthyvoulos Constantinidou, Anastasia Cancer Manag Res Review PURPOSE: Breast cancer brain metastasis (BCBM) represents a major clinical challenge. Can MRI help in advancements in the management of BCBM? This review discusses MRI developments and the corresponding potential advancements in BCBM management. METHODS: An exhaustive literature search was undertaken to identify studies which look into the potential of MRI in BCBM management. Seven hundred and eighty-four studies published from September 1984 to May 2020 were identified. Three topics are covered where MRI is not clinically established yet: 1) the prognosis of BCBM; 2) the screening of BC patients for BCBM development, and 3) the assessment of imaging features correlated to BC subtype. RESULTS: Thirty-six studies were considered eligible for the purposes of this review. On-going progress is made with the identification of different BCBM characteristics and MRI metrics that might be related to prognosis. Progress has been made with the identification of different BCBM characteristics, including BCBM location, degree of edema, white matter disruption, tumor edge sharpness, and temporal muscle thickness. A more accurate prediction of prognosis could lead to more suitable patient management and treatment. The use of MRI in BCBM screening of the high-risk breast cancer population remains a controversial subject. To date, there are no results from clinical trials; however, there is a rising number of relatively small studies that show concern on this subject and support BCBM screening. It is important to oncologists to be able to assess the tumor subtype non-invasively. MRI features, which have shown some correlation with subtype, include the number of tumors, location, and their distribution in the brain. Advanced tools and metrics have been produced to carry out radiological characteristics analysis on MRI images. Assessing MRI features in more detail could provide a more personalized management of patients. CONCLUSION: Developments in the use of MRI have the potential to improve BCBM management. Dove 2020-10-12 /pmc/articles/PMC7567538/ /pubmed/33116852 http://dx.doi.org/10.2147/CMAR.S252801 Text en © 2020 Hadjipanteli et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Hadjipanteli, Andria Doolan, Paul Kyriacou, Efthyvoulos Constantinidou, Anastasia Breast Cancer Brain Metastasis: The Potential Role of MRI Beyond Current Clinical Applications |
title | Breast Cancer Brain Metastasis: The Potential Role of MRI Beyond Current Clinical Applications |
title_full | Breast Cancer Brain Metastasis: The Potential Role of MRI Beyond Current Clinical Applications |
title_fullStr | Breast Cancer Brain Metastasis: The Potential Role of MRI Beyond Current Clinical Applications |
title_full_unstemmed | Breast Cancer Brain Metastasis: The Potential Role of MRI Beyond Current Clinical Applications |
title_short | Breast Cancer Brain Metastasis: The Potential Role of MRI Beyond Current Clinical Applications |
title_sort | breast cancer brain metastasis: the potential role of mri beyond current clinical applications |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567538/ https://www.ncbi.nlm.nih.gov/pubmed/33116852 http://dx.doi.org/10.2147/CMAR.S252801 |
work_keys_str_mv | AT hadjipanteliandria breastcancerbrainmetastasisthepotentialroleofmribeyondcurrentclinicalapplications AT doolanpaul breastcancerbrainmetastasisthepotentialroleofmribeyondcurrentclinicalapplications AT kyriacouefthyvoulos breastcancerbrainmetastasisthepotentialroleofmribeyondcurrentclinicalapplications AT constantinidouanastasia breastcancerbrainmetastasisthepotentialroleofmribeyondcurrentclinicalapplications |